BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 23, 2009
View Archived Issues
CSIR claims the discovery of novel anticancer agents
Read More
Novel PAPR inhibitors for the treatment of cancer described by Italian scientists
Read More
Positive modulators of nAChR in early development at NeuroSearch
Read More
Lundbeck discloses novel MCH-R1 ligands as antidepressants
Read More
Novartis presents novel PI3K inhibitors for the treatment of asthma
Read More
CDX-011 shows promising efficacy in advanced breast cancer patients
Read More
SS-1020, a new anti-estrogen candidate for treatment and prevention of breast cancer
Read More
AZD-1152 displays safety and efficacy in AML phase I/II trial
Read More
Unigene selects obesity drug UGP-281 as lead compound for development
Read More
Novel enzyme replacement therapy for Fabry disease in preclinical development
Read More
Fusion protein ACE-435 shows promise in cancer-induced cachexia therapy
Read More
UCB reports initial results for certolizumab pegol in Crohn's disease
Read More
BioDelivery Sciences presents phase II pain trial results for BEMA buprenorphine
Read More
Dual orexin receptor antagonist almorexant meets primary phase III endpoint
Read More
Vernakalant meets primary endpoint in European comparator study
Read More
Taro commences clinical trials with T-2007
Read More
Flamel initiates phase IIa IFN-alpha-2b XL trial in patients with chronic HCV
Read More
Ista submits supplemental NDA to FDA for once-daily XiDay
Read More
ChemoCentryx initiates phase II CCX-354 trial in rheumatoid arthritis
Read More
European CHMP recommends marketing authorization of Amgen's Prolia for osteoporosis
Read More
Ambit and Astellas to jointly develop and commercialize FLT3 kinase inhibitors
Read More
European CHMP recommends approval of Cangene's MAA for ImmunoGam
Read More
Cardium reports results from 10-year follow-up study of diabetic patients with foot ulcer
Read More
Myriad Pharmaceuticals to acquire Javelin Pharmaceuticals, including Dyloject
Read More
Seattle Genetics and GSK sign agreement for antibody-drug conjugate technology
Read More
Medicago reports phase I results for its avian flu pandemic vaccine
Read More